Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin

Journal of Bacteriology

Volumn 191, Issue 13, 2009, Pages 4482-4484

  Kohler, Thomas ^a   Weidenmaier, Christopher ^b   Peschel, Andreas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAURIC ACID; LINOLEIC ACID; PALMITOLEIC ACID; SKIN LIPID; TEICHOIC ACID; FATTY ACID;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIUM MUTANT; HUMAN; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; MUTATION; SKIN;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

FATTY ACIDS; HUMANS; MUTATION; SKIN; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 67649413346     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.00221-09     Document Type: Article

References (24)

1. Chamberlain, N. R., and B. Imanoel. 1996. Genetic regulation of fatty acid modifying enzyme from Staphylococcus aureus. J. Med. Microbiol. 44:125-129.
2. Clarke, S. R., R. Mohamed, L. Bian, A. F. Routh, J. F. Kokai-Kun, J. J. Mond, A. Tarkowski, and S. J. Foster. 2007. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1:199-212.
3. Cogen, A. L., V. Nizet, and R. L. Gallo. 2008. Skin microbiota: a source of disease or defence? Br. J. Dermatol. 158:442-455.
4. Foster, T. J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3:948-958.
5. Iordanescu, S., and M. Surdeanu. 1976. Two restriction and modification systems in Staphylococcus aureus NCTC8325. J. Gen. Microbiol. 96:277-281.
6. Kelsey, J. A., K. W. Bayles, B. Shafii, and M. A. McGuire. 2006. Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus. Lipids 41:951-961.
7. 2 and human β-defensin 3. Infect. Immun. 76:2169-2176.
8. Kraus, D., and A. Peschel. 2008. Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiol. 3:437-451.
9. Lampe, M. A., A. L. Burlingame, J. Whitney, M. L. Williams, B. E. Brown, E. Roitman, and P. M. Elias. 1983. Human stratum corneum lipids: characterization and regional variations. J. Lipid Res. 24:120-130.
10. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
11. Miller, S. J., R. Aly, H. R. Shinefeld, and P. M. Elias. 1988. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch. Dermatol. 124:209-215.
12. Montagna, W. 1963. Comparative aspects of sebaceous glands, p. 32-45. In W. Montagna, R. A. Ellis, and A. F. Silver (ed.), Advances in biology of skin, vol. 4. The sebaceous glands. Pergamon Press, Oxford, United Kingdom.
13. Neuhaus, F. C., and J. Baddiley. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67:686-723.
14. Niyonsaba, F., and H. Ogawa. 2005. Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. J. Dermatol. Sci. 40:157-168.
15. Rosenberg, M., D. Gutnick, and E. Rosenberg. 1980. Adherence of bacteria to hydrocarbon: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiol. Lett. 9:29-34.
16. Schröder, J. M., and J. Harder. 2006. Antimicrobial skin peptides and proteins. Cell. Mol. Life Sci. 63:469-486.
17. Sutcliffe, I. C., and N. Shaw. 1991. Atypical lipoteichoic acids of gram-positive bacteria. J. Bacteriol. 173:7065-7069.
18. Takigawa, H., H. Nakagawa, M. Kuzukawa, H. Mori, and G. Imokawa. 2005. Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus. Dermatology 211:240-248.
19. Weidenmaier, C., J. F. Kokai-Kun, S. A. Kristian, T. Chanturiya, H. Kalbacher, M. Gross, G. Nicholson, B. Neumeister, J. J. Mond, and A. Peschel. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10:243-245.
20. Weidenmaier, C., J. F. Kokai-Kun, E. Kulauzovic, T. Kohler, G. Thumm, H. Stoll, F. Gotz, and A. Peschel. 2008. Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 298:505-513.
21. Weidenmaier, C., and A. Peschel. 2008. Teichoic acids and related cell-wall glycopolymers in gram-positive physiology and host interactions. Nat. Rev. Microbiol. 6:276-287.
22. Weidenmaier, C., A. Peschel, Y. Q. Xiong, S. A. Kristian, K. Dietz, M. R. Yeaman, and A. S. Bayer. 2005. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J. Infect. Dis. 191:1771-1777.
23. Wille, J. J., and A. Kydonieus. 2003. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol. Appl. Skin Physiol. 16:176-187.
24. Xia, G., and A. Peschel. 2008. Toward the pathway of S. aureus WTA biosynthesis. Chem. Biol. 15:95-96.